insights_auto
Why is ILMN down 5.45%?
Dive Deeperchevron_right
ILMN:NASDAQ
Illumina Inc
$277.67
arrow_downward
-5.45%(-16.02) 1D
Oct 6, 11:54:38 AM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ILMN...
Open
$301.58
High
$309.34
Low
$272.35
Mkt. cap
38.98B
Avg. vol.
3.48M
Volume
2.22M
P/E ratio
51.61
52-wk high
$309.34
52-wk low
$88.00
EPS
$5.38
Beta
1.41
Shares outstanding
151.00M
No. of employees
9K
Open
$301.58
High
$309.34
Low
$272.35
Mkt. cap
38.98B
Avg. vol.
3.48M
Volume
2.22M
P/E ratio
51.61
52-wk high
$309.34
52-wk low
$88.00
EPS
$5.38
Beta
1.41
Shares outstanding
151.00M
No. of employees
9K
News stories
From web sources and news partners
ChartMill
·
1 hour ago
Tuesday's session: gap up and gap down stock in the S&P500 index
FinancialContent
·
3 hours ago
Stocks making big moves yesterday: Harley-Davidson, Illumina, TechnipFMC, Upstart, and DraftKings
AD HOC NEWS
·
7 hours ago
RBC raises target for Illumina stock to USD 310
Yahoo Finance
·
14 hours ago
Illumina (ILMN) Shares Skyrocket, What You Need To Know
Profile
Illumina, Inc. is an American biotechnology company, headquartered in San Diego, California. Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company provides a line of products and services that serves the sequencing, genotyping and gene expression, and proteomics markets, and serves more than 155 countries.
Illumina's customers include genomic research centers, pharmaceutical companies, academic institutions, clinical research organizations, and biotechnology companies. Wikipedia
About Illumina Inc
CEOJacob Thaysen
Employees8.62K
Founded1998
HeadquartersSan Diego, California, United States
SectorHealth care
Websiteillumina.com